InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Liquidia Corp

LQDA Clue Score52
United States Fiscal year ends December CIK 0001819576 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

21
Insider
Date
Role
Action
Shares
Price
Amount
Raman Singh
14 Sep 2026
Director
Sold after exercise
8,468
$66.16
$560.24K
Raman Singh
11 Sep 2026
Director
Sold after exercise
9,024
$68.62
$619.21K
Jason Adair
21 Aug 2026
Chief Business Officer
Sold after exercise
41,832
$69.09
$2.89M
Jason Adair
21 Aug 2026
Chief Business Officer
Sold after exercise
31,799
$69.09
$2.20M
Katherine Rielly-Gauvin
20 Aug 2026
Director
Sold after exercise
18,393
$72.23
$1.33M
Rajeev Saggar
19 Aug 2026
Chief Medical Officer
Sold after exercise
50,000
$74.06
$3.70M
Katherine Rielly-Gauvin
19 Aug 2026
Director
Sold after exercise
36,789
$74.99
$2.76M
Raman Singh
21 May 2026
Director
Sold after exercise
29,494
$60.13
$1.77M
Michael Kaseta
15 Apr 2026
CFO and COO
Sold after exercise
43,375
$40.14
$1.74M
Michael Kaseta
15 Apr 2026
CFO and COO
Sold after exercise
86,971
$40.14
$3.49M
Michael Kaseta
15 Apr 2026
CFO and COO
Sold after exercise
9,044
$40.14
$363.03K
Michael Kaseta
14 Apr 2026
CFO and COO
Sold after exercise
3,000
$40.00
$120.00K
Roger Jeffs
10 Apr 2026
Chief Executive Officer
Sold after exercise indirect
21,433
$40.12
$859.88K
Michael Kaseta
10 Apr 2026
CFO and COO
Sold after exercise
23,821
$40.14
$956.25K
Michael Kaseta
9 Apr 2026
CFO and COO
Sold after exercise
133,789
$40.24
$5.38M
Scott Moomaw
23 Mar 2026
Chief Commercial Officer
Sold after exercise
17,000
$36.81
$625.82K
Scott Moomaw
23 Mar 2026
Chief Commercial Officer
Sold after exercise
1,314
$36.48
$47.93K
Raman Singh
13 Mar 2026
Director
Sold after exercise
20,000
$36.04
$720.83K
Scott Moomaw
9 Mar 2026
Chief Commercial Officer
Sold after exercise
80,000
$35.32
$2.83M
Jason Adair
18 Nov 2025
Chief Business Officer
Sold after exercise
35,656
$30.03
$1.07M
Raman Singh
15 Sep 2025
Director
Sold after exercise
45,524
$25.81
$1.17M
Showing 250 of 363 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 389
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 25
Sales on a Rule 10b5-1 plan 196
Sales straight out of an exercise 37
Sales at will 97
Transactions with no price 0
Shares from compensation/vesting 11,469,218
Sales filed before the plan box existed 23
History held since 19 Nov 2020